Antidepressant medication use in palliative care

American Journal of Hospice and Palliative Medicine

Volumn 23, Issue 2, 2006, Pages 127-133

  Miller, Karl E ^a   Adams, Stephen M ^a   Miller, Martha M ^b  

^a UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

^b Adventa Hospice   (United States)

Author keywords

Antidepressant medication; Depression; Hospice; Palliative care

Indexed keywords

ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; DEPRESSION; DRUG UTILIZATION; HOSPICE CARE; HUMAN; METHODOLOGY; PALLIATIVE THERAPY; PATIENT ATTITUDE; REVIEW; UNITED STATES;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; DRUG UTILIZATION; HOSPICE CARE; HUMANS; PALLIATIVE CARE; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES;

EID: 33645331303     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910602300210     Document Type: Review

References (42)

1. Lloyd-Williams M, Dennis M, Taylor F: A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med. 2004; 18: 558-563.
2. Le Fevre P, Devereux J, Smith S, et al.: Screening for psychiatric illness in the palliative care inpatient setting: A comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med. 1999; 13: 399-407.
3. Akechi T, Okuyama T, Sugawara Y, et al.: Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: Associated and predictive factors. J Clin Oncol. 2004; 22: 1957-1965.
4. Lloyd-Williams M, Friedman T, Rudd N: A survey of antidepressant prescribing in terminally ill. Palliat Med. 1999; 13: 243-248.
5. Block SD: Assessing and managing depression in the terminally ill patient. Ann Intern Med. 2000; 132: 209-218.
6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000, p 356.
7. Periyakoil VS, Hallenbeck J: Identifying and managing preparatory grief and depression at the end of life. Am Fam Physician. 2002; 65: 883-890.
8. Lloyd-Williams M, Spiller J, Ward J: Which depression screening tools should be used in palliative care? Palliat Med. 2003; 17: 40-43.
9. Lloyd-Williams M, Dennis M, Taylor F, et al.: Is asking patients in palliative care, "Are you depressed?" appropriate? Prospective study. BMJ. 2003; 327: 372-373.
10. Holtom N, Barraclough J: Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care? Palliat Med. 2000; 14: 219-220.
11. Lloyd Williams M: Is appropriate to screen palliative care patients for depression? Am J Hosp Palliat Care. 2002; 19(2): 112-114.
12. Lloyd-Williams M, Dennis M, Taylor F: A prospective study to compare three depression screening tools in patients who are terminally ill. Gen Hosp Psychiatry. 2004; 26: 384-389.
13. Lloyd-Williams M: Difficulties in diagnosing and treating depression in the terminally ill cancer patient. Postgrad Med. 2000; 76: 555-558.
14. Hoyl MT, Alessi CA, Harker JO, et al.: Development and testing of a five-item version of the Geriatric Depression Scale. J Am Geriatr Soc. 1999; 47: 873-878.
15. Chochinov HM, Wilson KG, Enns M, et al.: Desire for death in the terminally ill. Am J Psychiatry. 1995; 152: 1185-1191.
16. Grov EK, Dahl AA, Fossa SD: Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase. Ann Oncol. 2005; 16(7): 1185-1191.
17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000, p 479.
18. Barraclough J: ABC of palliative care: Depression, anxiety and confusion. BMJ. 1997; 315(22 November): 1365-1368.
19. Potter WZ, Hollister LE: Antidepressant agents. In: Katzung BG (ed): Basic and Clinical Pharmacology, ed 9. New York: McGraw-Hill, 2003, 482-495.
20. Nelson JC: Tricyclic and heterocyclic drugs. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, pp 207-230.
21. Furukawa T, McGuire H, Barbui C: Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev. 2003(3).
22. Rosenbaum JF, Tollefson GD: Fluoxetine. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, 231-236.
23. Herr KD, Nemeroff CB: Paroxetine. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, 259-282.
24. Abramowicz M (ed): Which SSRI? Med Lett Drugs Ther. 2003; 45(1170).
25. Bernard SA: The interaction of medications used in palliative care. Hematol Oncol Clin North Am. 2002; 16: 641-655.
26. Micromedex Healthcare Series Vol. 125. Expires 9/2005. Accessed August 26, 2005.
27. Saiz-Ruiz J, Ibanez A, Diaz-Marsa M, et al.: Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(6): 1129-1134.
28. Detke MJ, Wiltse CQ Mallinckrodt CH, et al.: Duloxetine in the acute and long-term treatment of major depressive disorder: A placebo- and paroxetine-based controlled trial. Eur Neuropsychopharmacol. 2004; 14(6): 457-470.
29. Golden RN, Dawkins K, Nicholas L: Trazodone and nefazodone. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, 315-325.
30. Martinon-Torres G, Fioravanti M, Grimley Evans J: Trazodone for agitation in dementia. Cochrane Database Syst Rev. 2004(3): CD004990.
31. Williams JW, Mulrow CD, Chiquette E, et al.: Clinical guideline, part 2. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary. Ann Intern Med. 2000; 132: 743-756.
32. Guaiana G, Barbui C, Hotopf M: Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database of Syst Rev. 2003(2).
33. Roose SP, Laghrissi-Thode F, Kennedy JS, et al.: Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998; 279: 287-291.
34. Snow V, Lascher S, Mottur-Pilson C: Clinical guideline I: Pharmacologic treatment of acute major depression and dysthymia. Ann Intern Med. 2000; 132: 738-742.
35. Furukawa TA, Streiner DL, Young LT: Antidepressants and benzodiazepine for major depression. Cochrane Database Syst Rev. 2001(3).
36. Potash M, Breitbart W: Affective disorders in advanced cancer. Hematol Oncol Clin North Am. 2002; 16: 671-700.
37. Lynch ME: Antidepressants and analgesics: A review of randomized controlled trials. J Psychiatry Neurosci. 2001; 26(1): 30-36.
38. Saarto T, Wiffen PJ: Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005(3)CD005454.
39. Dworkin RH, Backonja M, Rowbotham MC, et al.: Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60: 1524-1534.
40. Sindrup SH, Bach FW, Madsen C, et al.: Venlafaxine versus imipramine in painful poly neuropathy: A randomized trial. Neurology. 2003; 60(8): 1284-1289.
41. Goldstein DJ, Lu Y, Detke MJ, et al.: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005; 116(1-2): 109-118.
42. Leo RJ, Barkin RL: Antidepressant use in chronic pain management: Is there a role for duloxetine? Prim Care Comp J Clin Psychiatry. 2003; 5: 118-123.